🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study was to evaluate the safety and tolerability ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-10
Trial ID
NCT02778113
Treatments Being Tested
Up to two hundred (200) adult participants with type 1 diabetes (T1D) aged ...
Status
Completed
Location
New England Diabetes and Endocrinology Center (NEDEC)
Start Date
2014-05
Trial ID
NCT02171130
Treatments Being Tested
The purpose of this study was to assess how glucagon administered nasally, ...
Status
Completed
Location
Barbara Davis Center for Diabetes
Start Date
2013-11
Trial ID
NCT01997411
Treatments Being Tested
The purpose of this study is to assess the efficacy, pharmacokinetics (PK),...
Status
Completed
Location
Barbara Davis Center for Diabetes
Start Date
2013-11
Trial ID
NCT01994746
Treatments Being Tested
In this study, participants with Type 1 diabetes received insulin through a...
Status
Completed
Location
Algorithme Pharma
Start Date
2012-03
Trial ID
NCT01556594
Treatments Being Tested
This study will investigate how the body processes nasal glucagon (NG) and ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2015-01
Trial ID
NCT02806973
Treatments Being Tested
This study will investigate how the body processes nasal glucagon and the e...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2014-06
Trial ID
NCT02806960
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of nasal ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2018-02-21
Trial ID
NCT03421379
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Completed
Location
Nemours Childrens Clinic
Start Date
2022-03-24
Trial ID
NCT04992312
Treatments Being Tested
This study provides information on immunogenicity of Nasal Glucagon (AMG504...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2013-09
Trial ID
NCT01959334
Treatments Being Tested